Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-009233

EVP & Group Pres, Cardiology sold 132,527 shares at $85.00 ($11,264,888)

  • EVP & Group Pres, Cardiology acquired 116,639 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-07 Exercise or conversion : show line 1 in the form 10b5-1 +59,021 $17.26 $1,018,702 235,376 D
2024-10-07 Exercise or conversion : show line 2 in the form 10b5-1 +57,618 $24.98 $1,439,298 292,994 D
2024-10-07 Sale : show line 3 in the form 10b5-1 −132,527 $85.00 $11,264,888 160,467 D
Open-market sales · 132,527 sh · avg $85.00 · $11,264,888

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-10-07 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −59,021 0 D
2024-10-07 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −57,618 0 D
Loading xslF345X05/doc4.xml…